These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7300021)

  • 1. The importance of vasopressin in the mechanism maintaining hypertension in the rat.
    Yazaki Y; Ohuchi Y; Ashida T; Saito T
    Jpn Circ J; 1981 Sep; 45(9):1116-20. PubMed ID: 7300021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
    Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M
    J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin as a possible contributor to hypertension.
    Yazaki Y; Ohuchi Y; Ashida T; Tsai R; Yoshizumi M
    Jpn Circ J; 1984 Feb; 48(2):188-95. PubMed ID: 6321816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of acute vasopressin infusion on blood pressure and plasma angiotensin II in normotensive and DOCA-salt hypertensive rats.
    Morton JJ; Garcia del Rio C; Hughes MJ
    Clin Sci (Lond); 1982 Feb; 62(2):143-9. PubMed ID: 7053914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central vasopressin is required for the complete development of deoxycorticosterone-salt hypertension in rats with hereditary diabetes insipidus.
    Liang J; Toba K; Ouchi Y; Nagano K; Akishita M; Kozaki K; Ishikawa M; Eto M; Orimo H
    J Auton Nerv Syst; 1997 Jan; 62(1-2):33-9. PubMed ID: 9021647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chronic angiotensin-converting enzyme blockade on pressor responses to exogenous angiotensin II, noradrenaline and vasopressin in deoxycorticosterone acetate salt (DOCA)-induced hypertensive rats.
    Gan EK; Abas A; Latiff A
    Jpn J Pharmacol; 1984 Oct; 36(2):147-51. PubMed ID: 6096611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of angiotensin receptors in the anterior hypothalamic preoptic area lowers blood pressure in DOCA-salt hypertensive rats.
    Kubo T; Yamaguchi H; Tsujimura M; Hagiwara Y; Fukumori R
    Hypertens Res; 2000 Mar; 23(2):109-18. PubMed ID: 10770257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of vasopressin receptors in deoxycorticosterone acetate-salt hypertension.
    Trinder D; Phillips PA; Risvanis J; Stephenson JM; Johnston CI
    Hypertension; 1992 Oct; 20(4):569-74. PubMed ID: 1398892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pressor responsiveness to vasopressin in the rat with DOC-salt hypertension.
    Crofton JT; Share L; Wang BC; Shade RE
    Hypertension; 1980; 2(4):424-31. PubMed ID: 7399626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osmotic stimulation in DOC-salt hypertension: vasopressin and blood pressure.
    Crofton JT; Share L; Brooks DP
    J Hypertens; 1986 Jun; 4(3):307-12. PubMed ID: 3734447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of vasopressin in the control of arterial pressure.
    McNeill JR
    Can J Physiol Pharmacol; 1983 Nov; 61(11):1226-35. PubMed ID: 6362804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin secretion in the New Zealand genetically hypertensive rat.
    Crofton JT; Share L; Baer PG; Allen CM; Wang BC
    Clin Exp Hypertens (1978); 1981; 3(5):975-89. PubMed ID: 7285722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidiuretic and pressor actions of vasopressin in age-dependent DOCA-salt hypertension.
    Zicha J; Kunes J; Lébl M; Pohlová I; Slaninová J; Jelínek J
    Am J Physiol; 1989 Jan; 256(1 Pt 2):R138-45. PubMed ID: 2912206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central renin-angiotensin system and the pathogenesis of DOCA-salt hypertension in rats.
    Itaya Y; Suzuki H; Matsukawa S; Kondo K; Saruta T
    Am J Physiol; 1986 Aug; 251(2 Pt 2):H261-8. PubMed ID: 3526927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressin response in collecting ducts of rats resistant to mineralocorticoid hypertension.
    Jeffries WB; McArdle S; Bockman C; Abel PW; Pettinger WA
    Hypertension; 1991 Jan; 17(1):63-71. PubMed ID: 1846120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depressor effects of captopril in DOCA-salt hypertensive rats: role of vasopressin.
    Igarashi Y; Suzuki H; Itaya Y; Kondo K; Saruta T
    J Hypertens; 1985 Apr; 3(2):149-53. PubMed ID: 3894513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced contractile sensitivity and vasopressin receptor affinity in DOCA-salt hypertension.
    Bockman CS; Jeffries WB; Pettinger WA; Abel PW
    Am J Physiol; 1992 Jun; 262(6 Pt 2):H1752-8. PubMed ID: 1535757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal function contributes to antihypertensive effect of vasopressin in DOCA-salt but not spontaneous hypertension.
    Wang H; McNeill JR
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H1842-50. PubMed ID: 7977814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of the antihypertensive effect of vasopressin withdrawal to sodium excretion in the Doca-salt hypertensive rat.
    Wang H; Wilson N; McNeill JR
    Clin Invest Med; 1993 Oct; 16(5):348-57. PubMed ID: 8261688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sodium, deoxycorticosterone and duration of hypertension on pressor responses in rats.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Physiol; 1982 Dec; 333():383-91. PubMed ID: 6763628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.